XML 42 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Fair value of Options Granted Under Weighted Average Assumptions

The fair value of each option granted during the period was estimated on the date of grant using the following weighted average assumptions:

 

2025

 

 

2024

 

Expected volatility

 

 

107

%

 

 

93

%

Expected term in years

 

 

7

 

 

 

6

 

Risk-free interest rate

 

 

3.9

%

 

 

4.3

%

Dividend yield

 

 

0

%

 

 

0

%

Summary of Option Activity

A summary of option activity for 2025 is presented below:

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2024

 

 

895,002

 

 

$

17.70

 

 

 

 

 

 

 

Granted

 

 

121,653

 

 

 

11.73

 

 

 

 

 

 

 

Exercised

 

 

(96,885

)

 

 

4.53

 

 

 

 

 

 

 

Forfeited

 

 

(23,858

)

 

 

13.37

 

 

 

 

 

 

 

Expired

 

 

(19,380

)

 

 

13.46

 

 

 

 

 

 

 

Outstanding at December 31, 2025

 

 

876,533

 

 

$

6.68

 

 

 

8.48

 

 

$

3,998,143

 

Vested or expected to vest at December 31, 2025

 

 

876,533

 

 

$

6.68

 

 

 

8.48

 

 

$

3,998,143

 

Exercisable at December 31, 2025

 

 

666,835

 

 

$

5.62

 

 

 

8.13

 

 

$

3,690,877

 

Summary of Non-vested Stock Activity

A summary of non-vested stock activity for 2025 is presented below:

 

Nonvested
Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Outstanding at December 31, 2024

 

 

80,646

 

 

$

11.25

 

Granted

 

 

69,533

 

 

 

12.57

 

Vested

 

 

(71,480

)

 

 

11.99

 

Forfeited

 

 

(833

)

 

 

22.10

 

Outstanding at December 31, 2025

 

 

77,866

 

 

$

11.63

 

Summary of Share-based Compensation Expense The impact on the Company’s results of operations from share-based compensation for the year ended December 31, 2025 and 2024, was as follows (in thousands):

 

2025

 

 

2024

 

Research and development

 

$

339

 

 

$

904

 

General and administrative

 

 

2,313

 

 

 

1,938

 

Total share-based compensation expense

 

$

2,652

 

 

$

2,842